Interferon combinations
US4806347A · kind A · utility
4Cited by
3References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 11, 1985 |
| Grant date | Feb 21, 1989 |
| Priority date | — |
| Expiry date | Dec 11, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are disclosed compositions and methods for treating tumors and viruses in humans by administering a combination of gamma interferon and delta-4 alpha-2 (Bgl II-1)/(Bgl II) alpha-1 hybrid interferon, preferably by injection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.